Physician profile
Kenneth Light
NPI 1104900919
$30,356.35
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $13K · 2021: $1,739 · 2022: $207.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Precision Spine, INC. | $25,475.09 | 2019-2020 | |
| Kyocera Medical Technologies, INC. | $3,200.00 | 2020-2021 | |
| Centinel Spine, LLC | $807.40 | 2019-2022 | |
| Cerapedics INC. | $116.75 | 2019 | |
| Organogenesis INC. | $115.03 | 2020 | |
| Aesculap Implant Systems, LLC | $107.60 | 2019 | |
| Silony Medical Corp. | $91.71 | 2019 | |
| Depuy Synthes Sales INC. | $88.81 | 2019 | |
| Collegium Pharmaceutical, INC. | $59.22 | 2019 | |
| Tersera Therapeutics LLC | $58.94 | 2019 | |
| 4web, INC. | $45.42 | 2019 | |
| Novartis Pharmaceuticals Corporation | $44.68 | 2019 | |
| Boston Scientific Corporation | $32.66 | 2019 | |
| Biodelivery Sciences International, INC. | $27.78 | 2019 | |
| Indivior INC. | $25.21 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.95 | 2019 | |
| Kaleo, INC. | $22.65 | 2019 | |
| Shionogi INC | $13.45 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Light listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.